Please provide your email address to receive an email when new articles are posted on . “We found a stepwise greater loss of lung density with increasing exacerbation frequency, predominantly in ...
Both dupilumab and mepolizumab were originally approved for asthma but were subsequently studied in patients with COPD who continue to experience symptoms and moderate-to-severe exacerbations despite ...
In an observational study that began enrollment last month, researchers will determine if continuous, remote lung sound monitoring via an FDA-cleared wearable is feasible in adults with COPD, ...
FLAME analysis suggests COPD exacerbation risk spikes for 3 months after stopping LAMA or ICS, underscoring adherence and careful step-down.
—A new study finds that some patients are proactive (they seek immediate treatment), while others tough it out (wishing to avoid the ‘hassle’ or ‘inconvenience’). What can clinicians do to better ...
According to a recent study, patients with an exacerbation of chronic obstructive pulmonary disease (COPD) have greater risks of both subsequent exacerbations and mortality. The odds of subsequent ...
Certain neighborhood characteristics, including higher poverty, more uninsured residents, and lower educational attainment, may lead to an increase in COPD-related emergency department visits and ...
Long-term oxygen therapy not beneficial for COPD with moderate desaturation. What is the risk of future COPD exacerbations, hospitalizations, and death among patients with COPD who had 1 or 0 ...
Altesa BioSciences, a clinical-stage pharmaceutical company dedicated to improving the lives of people with chronic lung diseases including COPD and asthma, today announced a $75 million ...
The risk of a CV adverse event of special interest did decrease over time after a moderate or severe COPD exacerbation. This article is part of MPR’s coverage of the CHEST Virtual 2020 meeting. In the ...
—Theses investigators found an increased risk for both individual and composite cardiovascular events following exacerbations of COPD, with sustained risk after 1 year regardless of severity. Reviewed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results